Table 1 Preoperative and perioperative data of the PVP and HoLEP groups.
Total (n = 1,193) | PVP (n = 439) | HoLEP (n = 754) | P-value | |
|---|---|---|---|---|
Mean ± SD or No. pts (%) | ||||
Patient demographics | ||||
Age (yr) | 68.5 ± 7.1 | 68.0 ± 8.0 | 68.7 ± 6.6 | 0.093 |
BMI (kg/m2) | 24.0 ± 3.0 | 23.9 ± 3.1 | 24.1 ± 3.0 | 0.420 |
PSA (ng/ml) | 4.2 ± 6.0 | 5.2 ± 8.0 | 3.6 ± 4.1 | <0.001* |
TPV (ml) | 56.8 ± 28.4 | 51.4 ± 32.0 | 60.0 ± 25.5 | <0.001* |
Symptom scores | ||||
Total I-PSS | 19.7 ± 7.6 | 20.6 ± 8.1 | 19.2 ± 7.4 | 0.003* |
VSS | 11.9 ± 5.2 | 12.3 ± 5.3 | 11.7 ± 5.1 | 0.029* |
SSS | 7.8 ± 3.5 | 8.3 ± 3.7 | 7.6 ± 3.4 | 0.001* |
QoL index | 4.2 ± 1.0 | 4.3 ± 1.0 | 4.2 ± 1.0 | 0.207 |
Uroflowmetric parameters | ||||
Qmax (ml/s) | 10.4 ± 4.8 | 10.6 ± 5.5 | 10.3 ± 4.6 | 0.548 |
PVR (ml) | 73.1 ± 102.5 | 83.2 ± 117.3 | 67.2 ± 92.3 | 0.018* |
BVE (%) | 73.2 ± 24.1 | 72.0 ± 24.5 | 73.9 ± 23.9 | 0.225 |
Urodynamic parameters | ||||
FDV (mL) | 187.4 ± 82.5 | 182.1 ± 90.4 | 190.4 ± 77.5 | 0.112 |
MCC (mL) | 378.8 ± 117.5 | 405.0 ± 89.5 | 365.3 ± 127.5 | <0.001* |
IDC | 478 (40.1) | 148 (33.7) | 330 (43.8) | 0.028* |
BOOI | 40.6 ± 27.1 | 35.4 ± 28.2 | 43.7 ± 26.1 | <0.001* |
BCI | 94.6 ± 30.1 | 88.7 ± 31.4 | 98.1 ± 28.8 | <0.001* |
Perioperative data | ||||
Operation time (min) | 69.7 ± 37.9 | 72.1 ± 46.5 | 68.5 ± 32.5 | 0.018* |
Enucleation ratio | 0.78 ± 0.47 | |||
Used energy (joules) | 102.5 ± 63.5 | 129.1 ± 90.8 | 88.7 ± 35.8 | <0.001* |